Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY

McLaughlin Melissa sold 3,910 Alnylam Pharmaceuticals, Inc. shares (Form 4)

Traded Apr 2 to Apr 6, 2026 · Filed Apr 7, 2026

From Apr 2 to Apr 6, 2026, McLaughlin Melissa (Chief Human Resources Officer) sold 3,910 Alnylam Pharmaceuticals, Inc. shares at an average US$325.92 for US$1.27M under a trading plan, leaving 9,443 shares. Filed Apr 7, 2026 (Form 4).

Sold
3,910 shares
Price
US$325.92 average (US$316.61 to US$333.94)
Value
US$1.27M
Holding after
9,443 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Human Resources Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 2, 2026Common StockSale265US$316.6113,088Direct
Apr 2, 2026Common StockSale359US$317.4412,729Direct
Apr 2, 2026Common StockSale209US$318.4712,520Direct
Apr 2, 2026Common StockSale86US$319.6912,434Direct
Apr 2, 2026Common StockSale147US$320.6212,287Direct
Apr 2, 2026Common StockSale224US$321.6412,063Direct
Apr 2, 2026Common StockSale245US$322.8611,818Direct
Apr 2, 2026Common StockSale81US$323.6411,737Direct
Apr 2, 2026Common StockSale8US$325.4911,729Direct
Apr 6, 2026Common StockSale56US$320.1411,673Direct
Apr 6, 2026Common StockSale909US$329.7610,764Direct
Apr 6, 2026Common StockSale829US$330.469,935Direct
Apr 6, 2026Common StockSale293US$331.899,642Direct
Apr 6, 2026Common StockSale199US$333.949,443Direct

Source

View original at SEC

Related